Dicerna Pharmaceuticals (DRNA) PT Raised to $29 at Stifel

February 28, 2020 5:18 AM EST Send to a Friend

Stifel analyst Stephen Willey raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Dicerna Pharmaceuticals (DRNA) PT Raised to $29 at Stifel

Member Login

Free News Feed